Biocon - Channel Breakout - Long term investing idea

Biocon

PE = 32 less than Industry PE
PBV also less than Industry PBV
PEG = 2.4
Low ROE, ROCE
Good sales and profit growth in last 5 years.
Last 1 year sales and profit growth are excellent - 48% sales growth, 83% profit growth
Stable promoter holding

Trade active:

Less than ideal quarterly results

Mar 2024
BIOCON
QOQ
👉Revenue drops -0.94% to 3917cr
👉Profit drops -70.39% to 223cr
👉EPS drops -79.45% to 1.13
👉EBITDA rose 1.11% to 913
👉EBITDA Margin drops 0.00% BPS to 23%
YOY
👉Revenue rose 3.79% from 3774cr
👉Profit drops -46.14% from 414cr
👉EPS drops -56.70% from 2.61
👉EBITDA drops -4.60% from 957
👉EBITDA Margin drops -2.00% BPS from 25%
Fundamentals
👉Stock Price is 269.7( as of 3/31/2024)
👉Stock PE is 31.65
👉Stock EPS is 8.52
👉Dividend Announced of Rs.0.5
Growth
👉2 Year Revenue CAGR is 34.28%
👉2 Year Profit CAGR is 29.67%
👉2 Year EPS CAGR is 25.61%
👉2 Year Price CAGR is -11.18%"

However at end of year, compared to last year. company has increased revenue nearly by a quarter and profits have nearly doubled. Margins remain mostly same and promoter holding is stable. Continue to stay invested